CWM
SLS icon

CIBC World Markets’s SELLAS Life Sciences SLS Stock Holding History

CIBC World Markets’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$25.8K Buy
+11,759
New +$18K ﹤0.01% 1517

Other funds holding SLS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CIBC World Markets's SLS Position: Q2 2025 in Review

CIBC World Markets opened a new position in SELLAS Life Sciences (SLS) in Q2 2025: 11,759 shares worth $25.8K. The stake represents ﹤0.01% of the portfolio and ranks #1517 among its holdings.

79 funds tracked by Wall St. Rank hold SLS as of Q2 2025.

  • CIBC World Markets held 11,759 shares of SELLAS Life Sciences worth $25.8K as of Q2 2025.
  • SELLAS Life Sciences was a new CIBC World Markets position in Q2 2025.
  • SELLAS Life Sciences made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1517 holding.
  • 79 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.